- Home
- TARA vs POWW Comparison
TARA vs POWW Comparison
Compare TARA & POWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARA | POWW |
|---|---|---|
| Founded | N/A | 1990 |
| Country | United States | United States |
| Employees | N/A | 81 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Ordnance And Accessories |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 268.5M | 242.8M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | TARA | POWW |
|---|---|---|
| Price | $5.17 | $1.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 2 |
| Target Price | ★ $23.60 | $2.40 |
| AVG Volume (30 Days) | 523.4K | ★ 526.0K |
| Earning Date | 05-01-2026 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,948,000.00 | N/A |
| Revenue This Year | N/A | $14.56 |
| Revenue Next Year | N/A | $0.50 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.77 | $1.08 |
| 52 Week High | $7.82 | $2.23 |
Technical Indicators
Market Signals| Indicator | TARA | POWW |
|---|---|---|
| Relative Strength Index (RSI) | 46.37 | 44.49 |
| Support Level | $4.92 | $1.62 |
| Resistance Level | $5.44 | $2.21 |
| Average True Range (ATR) | 0.25 | 0.08 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 41.54 | 19.67 |
Price Performance
Historical ComparisonAbout TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).
About POWW AMMO Inc.
Outdoor Holding Co Formerly AMMO Inc is the owner of GunBroker.com, the online marketplace serving the firearms and shooting sports industries, and a vertically integrated producer of high-performance ammunition and components. It engages in the design, manufacture, and market of ammunition products in the Shooting sports industry in the United States. The firm's product segment comprises Ammunition and Marketplace. The Ammunition segment engages in the design, production, and marketing of ammunition and ammunition component products and the marketplace segment consists of the GunBroker.com marketplace. The company generates the majority of its revenue from the Ammunition segment.